Metagenomi director Laurence Reid acquires common shares worth $23,403.95
MGX•Director buys open-market shares
Metagenomi director Laurence Reid bought 20,000 Metagenomi Therapeutics common shares in open-market purchases priced around $1.17-$1.18.
Directly held stake rose to 20,000 shares following the transactions.
